Organon Denmark ApS: Financial statements 2022
CVR: 41193093
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Organon Denmark ApS (CVR 41193093) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 61,971,000 and a net result of DKK 2,139,000 compared with DKK 857,000 the year before. That is an increase of 21.6% compared with the year before. The profit margin was 3.5%. Equity in the 2022 report amounted to DKK 26,558,000. The solvency ratio was 60.4%. The company had 16 employees in the financial year.
- Revenue
- DKK 61,971,000
- Gross Profit
- DKK 11,941,000
- Profit/Loss
- DKK 2,139,000
- Equity
- DKK 26,558,000
- Total Assets
- DKK 44,003,000
- Employees
- 16
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 62M | 11.9M | 2.1M | 26.6M | 16 |
| 2021 | 51M | 8.6M | 857K | 24.4M | 13 |
| 2020 | 49.2M | 4.4M | 1.3M | 22.7M | 5 |
Official annual report
Keep an eye on Organon Denmark ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Organon Denmark ApS has published its annual report for 2021. Revenue came to DKK 50,982,000, and the net result was DKK 857,000.
About Organon Denmark ApS
Organon Denmark ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2020. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named OBS Denmark ApS. The management consists of Anne Bitzer, Karl Johan Sundt and Sofia Raquel Paulos Ferreira Alves da Silva. The company is owned by OBS Human Health Holding B.V.. The company has 6 employees (2026). In 2025, the company reported revenue of DKK 61,554,000 and a net result of DKK 3,139,000 compared with DKK 2,428,000 the year before. Equity in the 2025 report amounted to DKK 31,049,000.